+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Summit Therapeutics plc - logo

Summit Therapeutics is a biopharmaceutical company focussed on the development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile. The company is developing Ezutromid, an utrophin modulator product candidate that is in Phase II clinical trials used for to treat Duchenne muscular dystrophy disease. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.

Gonorrhea Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gonorrhea Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 140 Pages
  • Global
From
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2025 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
From
Clostridium Difficile Treatment - Global Strategic Business Report - Product Thumbnail Image

Clostridium Difficile Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 192 Pages
  • Global
From
2021 Clinical Trial Analytics of the Microbiome Landscape - Product Thumbnail Image

2021 Clinical Trial Analytics of the Microbiome Landscape

  • Report
  • April 2021
  • 9 Pages
  • Global
Collaboration Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 950 Pages
  • Global
From
From
China Pharmaceutical Companies and Drugs Pipeline Insight 2023 - Product Thumbnail Image

China Pharmaceutical Companies and Drugs Pipeline Insight 2023

  • Drug Pipelines
  • September 2023
  • 2800 Pages
  • China
From
Gonorrhoea - Pipeline Insight, 2025 - Product Thumbnail Image

Gonorrhoea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025

  • Report
  • April 2025
  • 400 Pages
  • Global
From
Ridinilazole Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ridinilazole Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Loading Indicator